Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant.
Fowler
D
D
National Cancer Institute, Experimental Transplantation and Immunology Branch, USA.
Hou
J
J
Foley
J
J
Hakim
F
F
Odom
J
J
Castro
K
K
Carter
C
C
Read
E
E
Gea-Banacloche
J
J
Kasten-Sportes
C
C
Kwak
L
L
Wilson
W
W
Levine
B
B
June
C
C
Gress
R
R
Bishop
M
M
D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D006086:Graft vs Host Disease; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation; D033581:Stem Cell Transplantation / Q000379:methods*; D018418:Th2 Cells / Q000637:transplantation*; D013997:Time Factors